The "Alluvi" designation refers to a specific brand or product line of BPC-157 and TB-500 peptides. This page provides an educational overview of brand-level composition standards, manufacturing quality considerations, and laboratory verification methods applicable to Alluvi-branded and similar peptide products in the research market.
1.BPC-157 And TB-500 Understanding Peptide Brand Designations
In the research peptide market, various brand names are used to distinguish products from different manufacturers or suppliers. The "Alluvi" brand represents one such designation for BPC-157 and TB-500 peptide products. Brand designations in the peptide research market typically indicate the manufacturer, grade level, or specific formulation characteristics of the product.
It is important to understand that brand names do not change the fundamental molecular properties of the peptides. BPC-157, regardless of brand, has the same amino acid sequence (GEPPPGKPADDAGLV), molecular weight (~1,419.55 g/mol), and molecular formula (C62H98N16O22). Similarly, TB-500's molecular properties are consistent across brands. For fundamental peptide properties, see our comparative analysis page and peptide classification page.
2.BPC-157 And TB-500 Brand-Level Quality Considerations
What distinguishes one peptide brand from another is not the peptide molecule itself, but rather the quality of manufacturing, purity, documentation, and customer support. When evaluating any peptide brand, including Alluvi, the following quality criteria should be assessed:
| Quality Criterion | What to Verify | Documentation Source |
|---|---|---|
| Purity | ≥95% by HPLC (ideally ≥98%) | Certificate of Analysis |
| Peptide Identity | Mass spectrometry confirmation | CoA / Mass Spec Report |
| Peptide Content | 70-90% of net weight | CoA |
| Endotoxin Level | Below threshold for research use | Endotoxin Test Report |
| Amino Acid Analysis | Confirms sequence composition | AAA Report |
| Sterility | Sterile preparation confirmed | Sterility Test Report |
3.BPC-157 And TB-500 Manufacturing Standards for Research Peptides
Research-grade peptides are manufactured using solid-phase peptide synthesis (SPPS). The manufacturing process involves:
- Resin loading – The C-terminal amino acid is attached to a solid resin support
- Sequential coupling – Each subsequent amino acid is added in sequence using coupling reagents
- Deprotection – Protective groups are removed after each coupling cycle
- Cleavage – The completed peptide is cleaved from the resin
- Purification – The crude peptide is purified using reversed-phase HPLC
- Lyophilization – The purified peptide is freeze-dried into a stable powder
- Quality control – The final product is tested for purity, identity, and content
Quality manufacturers follow Good Manufacturing Practice (GMP) principles, even for research-grade products. GMP compliance ensures consistency, traceability, and quality in the manufacturing process.
When evaluating any peptide brand, researchers should request: (1) Full CoA with HPLC chromatogram, (2) Mass spectrometry data, (3) Manufacturing date and expiry, (4) Storage and handling instructions, (5) Lot traceability information. Any brand that cannot provide these documents should be approached with caution.
4.BPC-157 And TB-500 Laboratory Verification Methods
Regardless of brand, researchers should independently verify peptide quality before use in experiments. Key verification methods include:
- Reversed-phase HPLC – Verifies purity and detects impurities. A single major peak at the expected retention time indicates high purity.
- Mass spectrometry (MALDI-TOF or ESI-MS) – Confirms molecular weight matches expected value (1,419.55 Da for BPC-157; 4,963.55 Da for TB-500)
- Amino acid analysis – Confirms amino acid composition matches the expected sequence
- Solubility test – Verifies the peptide dissolves properly in the intended solvent
- Visual inspection – The lyophilized powder should be white/off-white; the reconstituted solution should be clear
For information about proper reconstitution and preparation, see our injection preparation page. For dosing calculations, see our dosing terminology page.
5.BPC-157 And TB-500 Alluvi Product Composition Analysis
Alluvi-branded BPC-157 and TB-500 products should contain the same peptide molecules as any other brand. The key differentiators are:
- Formulation type – Lyophilized powder, pre-mixed solution, or blend
- Available dosage forms – Vials, nasal spray, pen systems
- Net content per vial – Commonly 2 mg, 5 mg, or 10 mg
- CoA completeness – Whether full analytical documentation is provided
- Purity grade – Typically 98%+ for research-grade products
Researchers should verify these parameters through the provided CoA and independent testing where possible. For information about research documentation standards, see our protocol framework page.